The human impact of ADPKD

An image of a young girl standing outside and wearing headphones as she looks ahead.

10 years old

Patients start to develop kidney cysts in childhood, although symptoms don’t typically occur until adulthood.

An image of a woman sitting on a examination bed in a doctor's office. She is wearing a blood pressure cuff and there is a clinician measuring her blood pressure.

40 years old

At first, patients can experience symptoms or signs including high blood pressure, blood in the urine, abdominal and side swelling or pain, urinary tract infections and kidney stones.

An image of a smiling elderly man seated on a chair. There is a clinician wearing blue scrubs and a stethoscope who is standing behind him. The clinician has their right hand placed on the man's shoulder and the man has his hand placed over the top.

60 years old

Approximately 50% of patients develop end-stage kidney failure that requires dialysis or a kidney transplant to treat.

ADPKD at a glance

An icon of a navy blue globe with an orange stand.

An urgent need to create treatments

ADPKD affects 1 in every 1,000 people.1

An icon of two strands of RNA next to each other. The strand on the left is navy blue and the strand on the right is orange. Both strand are otherwise identical. They are both gently curved vertical lines with short horizontal lines staggered downwards like the rungs of a ladder.

ADPKD is a monogenic disease

Approximately 80% of ADPKD patients have a mutation in one of their two copies of the PKD1 gene.2 ADPKD patients have a mutation in one of their two copies of the PKD1 gene – this mutation is present in all the cells in their body but it causes disease in the renal tubular cells of the kidney. The PKD1 gene mutation creates an unstable RNA message – this leads to approximately half as much PC1 protein production as is required to function normally.

An icon of a set of navy blue kidneys connected by a large blood vessel with orange cysts all over them.

Development of fluid-filled cysts

Patients with ADPKD develop fluid-filled cysts in their kidneys that destroy kidney function, with more than 50% of patients reaching end-stage renal failure in their 50s.3 The cysts cause patient’s kidneys to expand up to the size of a football, significantly larger than a normal fist-sized kidney. Underproduction of the PC1 protein causes increased epithelial cell proliferation and fluid secretion, which leads to cyst formation in the kidneys. Over time, insufficient PC1 protein production causes these cysts to increase in size and count, which leads the kidneys to enlarge (up to the size of a football) and decline in function – this results in renal failure for most patients, with the patient ultimately requiring regular dialysis and organ transplant

Mechanism of action of PYC-003 for ADPKD

ADPKD patients have a mutation in one copy of the PKD1 gene – this leads to their kidney cells producing half as much PC1 protein as is required for normal function. PYC-003 increases PKD1 gene expression, which could arrest disease progression, enable damaged kidneys to regenerate, and restore function. This video provides an overview of the ADPKD disease and the mechanism of action for PYC’s candidate PYC-003.

References

  1. Willey C, Kamat S, Stellhorn R et al. Analysis of Nationwide Data to Determine the Incidence and Diagnosed Prevalence of Autosomal Dominant Polycystic Kidney Disease in the USA: 2013-2015. Kidney Dis (Basel). 2019 Mar;5(2):107-117. doi: 10.1159/000494923. ↩︎
  2. Cordido A, Besada-Cerecedo L, García-González MA. The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians. Front Pediatr. 2017 Dec;5:279. doi: 10.3389/fped.2017.00279. ↩︎
  3. Cloutier M, Manceur AM, Guerin A et al. The societal economic burden of autosomal dominant polycystic kidney disease in the United States. BMC Health Serv Res. 2020 Feb;20(1):126. doi: 10.1186/s12913-020-4974-4. ↩︎